Coronary Artery Disease and Atherosclerosis

References

American Heart Association. Heart Disease and Stroke Statistics, 2004. Available at: http://www.americanheart.org/downloadable/heart/1079736729696HDSStats2004UpdateREV3–19–04.pdf.

American Heart Association. Cholesterol-Lowering Drugs: AHA Recommendation, 2005. Available at: http://www.americanheart.org/presenter.jhtml?identifier=4510. Accessed March 8, 2006.

Antoniades C, Tousoulis D, et al. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: The effects of vitamin C. Diabet Med. 2004 Jun;21(6):552–8.

Atkinson C, Compston JE, et al. The effects of phytoestrogen isoflavones on bone density in women: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2004;79(2):326–33.

Beckman JA, Creager MA, et al. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–81.

Benagiano G, Farris M. Why a consensus conference on hormone replacement therapy and the cardiovascular system? Maturitas. 2004;47(4):245–53.

Bots ML, Elwood PC, et al. Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health. 2002;56 Suppl 1:i14–18.

Bueno R, Alvarez de Sotomayor M, et al. L-carnitine and propionyl-L-carnitine improve endothelial dysfunction in spontaneously hypertensive rats: Different participation of NO and COX-products. Life Sci. 2005 Sep 9;77(17):2082–97.

Cockcraft JR. Exploring vascular benefits of endothelium-derived nitric oxide. Am J Hypertens. 2005 Dec;18(12 Pt 2):177S–83S. Review.

Crisafulli A, Altavilla D, et al. Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women. J Clin Endocrinol Metab. 2004a;89(1):188–92.

Crisafulli A, Marini H, et al. Effects of genistein on hot flushes in early postmenopausal women: A randomized, double-blind EPT- and placebo-controlled study. Menopause. 2004b;11(4):400–4.

Di Napoli M, Papa F, et al. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke. 2001;32(1):133–8.

Dietrich M, Block G, et al. Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers. Cancer Epidemiol Biomarkers Prev. 2002;11(1):7–13.

Fang JC, Kinlay S, et al. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: A randomised trial. Lancet. 2002;359(9312):1108–13.

Guilland JC, Favier A, et al. [Hyperhomocysteinemia: An independent risk factor or a simple marker of vascular disease? 2. Epidemiological data]. Pathol Biol (Paris). 2003;51(2):111–21.

Hak AE, Witteman JC, et al. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam study. J Clin Endocrinol Metab. 2002;87(8):3632–9.

Harris A, Devaraj S, et al. Oxidative stress, alpha-tocopherol therapy, and atherosclerosis. Curr Atheroscler Rep. 2002;4(5):373–80.

Haynes WG. Hyperhomocysteinemia, vascular function and atherosclerosis: Effects of vitamins. Cardiovasc Drugs Ther. 2002;16(5):391–9.

Hibatallah J, Carduner C, et al. In-vivo and in-vitro assessment of the free-radical-scavenger activity of Ginkgo flavone glycosides at high concentration. J Pharm Pharmacol. 1999;51(12):1435–40.

Howe AM, Webster WS. Warfarin exposure and calcification of the arterial system in the rat. Int J Exp Pathol. 2000 Feb;81(1):51–6.

Janisch KM, Williamson G, et al. Properties of quercetin conjugates: Modulation of LDL oxidation and binding to human serum albumin. Free Radic Res. 2004;38(8):877–84.

Jie KSG, et al. Vitamin K status and bone mass in women with and without aortic atherosclerosis: A population based study. Calcif Tiff Int. 1996;59:352–6.

Kaiser KP, Feinendegen LE. Planar scintigraphy versus PET in measuring fatty acid metabolism of the heart. Herz. 1987 Feb;12(1):41–50.

Koenig W. Fibrinogen and coronary risk. Curr Cardiol Rep. 1999;1(2):112–8.

Koscielny J, Klussendorf D, et al. The antiatherosclerotic effect of Allium sativum. Atherosclerosis. 1999 May;144(1):237–49.

Kudolo GB, Wang W, et al. Oral ingestion of Ginkgo biloba extract reduces thiobarbituric acid reacting (TBAR) substances in washed platelets of healthy subjects. J Herb Pharmacother. 2003;3(4):1–15.

Kuhlman DR, Schaefer CA, et al. Quercetin-induced induction of the NO/cGMP pathway depends on Ca2+-activated K+ channel-induced hyperpolarization-mediated Ca2+-entry into cultured human endothelial cells. Planta Med. 2005 Jun;71(6):520–4.

LaRosa JC. Lipids and cardiovascular disease: Do the findings and therapy apply equally to men and women? Womens Health Issues. 1992;2(2):102–111; discussion 111–103.

Lee W, Min WK, et al. Long-term effects of green tea ingestion on atherosclerotic biological markers in smokers. Clin Biochem. 2005b Jan;38(1):84–7.

Lee WJ, Lee IK, et al. Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arterioscler Thromb Vasc Biol. 2005a Dec;25(12):2488–94.

Ma J, Hennekens CH, et al. A prospective study of fibrinogen and risk of myocardial infarction in the Physicians’ Health Study. J Am Coll Cardiol. 1999;33(5):1347–52.

Machha A, Mustafa MR. Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J Cardiovasc Pharmacol. 2005 Jul;46(1):36–40.

Massberg S, Enders G, et al. Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood. 1999;94(11):3829–38.

McSweeney JC, Cody M, et al. Women’s early warning symptoms of acute myocardial infarction. Circulation. 2003;108(21):2619–23.

Mosca L, Marcellini S, et al. Modulation of apoptosis and improved redox metabolism with the use of a new antioxidant formula. Biochem Pharmacol. 2002;63(7):1305–14.

Mouren X, Caillard P, et al. Study of the antiischemic action of EGb 761 in the treatment of peripheral arterial occlusive disease by TcP02 determination. Angiology. 1994;45(6):413–7.

Munteanu A, Zingg JM, et al. Anti-atherosclerotic effects of vitamin E—myth or reality? J Cell Mol Med. 2004;8(1):59–76.

Oka RK, Szuba A, et al. A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease. Vasc Med. 2005 Nov;10(4):265–74.

Orekhov AN, Tertov VV, et al. Direct anti-atherosclerosis-related effects of garlic. Ann Med. 1995 Feb;27(1):63–5.

Packard CJ, O’Reilly DS, et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med. 2000;343(16):1148–55.

Packer L, Kraemer K, et al. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition. 2001;17(10):888–95.

Reiterer G, Toborek M, et al. Quercetin protects against linoleic acid-induced porcine endothelial cell dysfunction. J Nutr. 2004 Apr;134(4):771–5.

Riba R, Nicolaou A, et al. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis. 2004;175(1):69–75.

Rifai N. C-reactive protein and coronary heart disease: Diagnostic and therapeutic implications for primary prevention. Cardiovasc Toxicol. 2001;1(2):153–7.

Rifai N, Ridker PM. High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease. Clin Chem. 2001;47(3):403–11.

Rosano GM, Vitale C, et al. Hormone replacement therapy and cardioprotection: The end of the tale? Ann N Y Acad Sci. 2003;997:351–7.

Rosenfeldt F, Marasco S, et al. Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue. J Thorac Cardiovasc Surg. 2005 Jan;129(1):25–32.

Rossouw JE, Anderson GL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.

Sannito N, Lovreglio V. [Women and cardiovascular diseases]. Minerva Cardioangiol. 2002;50(2):107–16.

Sano J, Inami S, et al. Effects of green tea intake on the development of coronary artery disease. Circ J. 2004 Jul;68(7):665–70.

Sans S, Kesteloot H, et al. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J. 1997;18(12):1231–48.

Sasazuki S, Kodama H, et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol. 2000 Aug;10(6):401–8.

Simoncini T, Mannella P, et al. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology. 2003;144(8):3449–55.

Sola S, Mir MQ, et al. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: Results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation. 2005 Jan 25;111(3):343–8.

Sondergaard HP, Hansson LO, et al. The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clin Chim Acta. 2004;342(1-2):93–8.

Spagnoli LG, Orlandi A, et al. Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits. Atherosclerosis. 1995 Apr 7;114(1):29–44.

Squadrito F, Altavilla D, et al. Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study. Am J Med. 2003;114(6):470–6.

Thompson SG, Kienast J, et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332(10):635–41.

Touyz RM. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: Role of angiotensin II. Exp Physiol. 2005 Jul;90(4):449–55. Review.

Verma SK, Rajeevan V, et al. Effect of garlic (Allium sativum) oil on exercise tolerance in patients with coronary artery disease. Indian J Physiol Pharmacol. 2005 Jan;49(1):115–8.

Wilhelmsen L, Svardsudd K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311(8):501–5.

Williams MJ, Sutherland WH, et al. Aged garlic extract improves endothelial function in men with coronary artery disease. Phytother Res. 2005 Apr;19(4):314–9.

Wiseman LR, Brogden RN. Propionyl-L-carnitine. Drugs Aging. 1998 Mar;12(3):243–8; discussion 249–50.

Wu D, Liu L, et al. Vitamin E (E) increases prostacyclin (Pgi2) and prostaglandin (Pg) E2 production by human aorta endothelial cell (Haec) by differentially modulating cyclooxygenase (Cox) and phospholipase A2 (Pla2) activities. Experimental Biology. 2004;18(5 Pt Ii):a860.

Yin WH, Chen JW, et al. L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease. Clin Nutr. 2005 Dec;24(6):988–97.